Date published: 2025-12-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRR1 Activators

KRR1 is a fundamental gene that encodes a small subunit processome component homolog, playing a crucial role in the biogenesis of the ribosomal 40S subunit. It is a protein coding gene, intricately involved in the early stages of pre-18S rRNA processing, a cornerstone process for the production of functional ribosomes. The KRR1 protein is involved in RNA binding activity and has been shown to be essential for cellular survival due to its involvement in ribosome assembly. The gene is expressed ubiquitously across various tissues, highlighting its importance in the fundamental operations of eukaryotic cells. Expression levels of KRR1 are indicative of a cell's ribosomal biogenesis activity, which is closely tied to the cell's growth and division cycles. Given its central role in the cellular machinery, the regulation of KRR1 expression is a finely tuned process, responsive to a variety of intracellular signals and extracellular cues.

Research has identified several chemical compounds that could serve as activators to induce the expression of KRR1. Compounds such as β-Estradiol are known to engage specific receptors that may lead to the transcriptional activation of genes involved in cell growth, which could include KRR1 due to its role in ribosome assembly. Similarly, DNA-binding agents like Mithramycin A might indirectly lead to an increase in KRR1 expression by altering transcriptional initiation processes. Agents that cause cellular stress, such as Tunicamycin, which inhibits N-linked glycosylation, can trigger a cellular response aiming to bolster ribosome production, stimulating an upregulation of KRR1 as a compensatory mechanism. Furthermore, the cellular response to DNA damage, as seen with compounds like Etoposide and Doxorubicin, may also prompt an elevation in KRR1 expression, as the need for ribosomal biogenesis can be heightened during the repair processes. It is important to note that while these compounds have been associated with changes in gene expression patterns, the direct relationship between these compounds and the specific induction of the KRR1 gene is a subject for rigorous scientific investigation. The complex interplay between these chemical compounds and the cellular environment underscores the delicate balance of gene expression regulation within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$62.00
$178.00
8
(1)

β-Estradiol may upregulate KRR1 expression by engaging estrogen receptors, which can initiate transcriptional changes supporting cellular proliferation and rRNA processing requirements.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A could trigger the upsurge in KRR1 expression by binding to GC-rich sequences in gene promoters, altering transcriptional initiation and ribosomal biogenesis pathways.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Through stabilization of microtubules, Taxol may indirectly stimulate KRR1 expression by activating signaling cascades that prompt cellular growth and corresponding increases in ribosomal assembly.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Camptothecin might induce KRR1 expression by eliciting DNA damage responses, necessitating augmented ribosomal biogenesis for repair processes.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

In response to Methotrexate's interference with nucleotide synthesis, cells may increase KRR1 expression to boost ribosome production and overcome deficits in nucleotide availability.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin may provoke an elevation in KRR1 expression as part of a broader cellular response to DNA intercalation and the consequent demand for protein synthesis in repair mechanisms.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide, by causing DNA strand breaks, could engender a surge in KRR1 expression to meet the heightened requirements for ribosome biogenesis during DNA damage repair.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

The formation of DNA adducts by Cisplatin may lead to an upsurge in KRR1 expression as a cellular strategy to enhance ribosomal function for stress response protein synthesis.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Tunicamycin's inhibition of glycosylation could precipitate an increase in KRR1 expression as part of the unfolded protein response, aiming to maintain ribosomal output under endoplasmic reticulum stress.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib may promote KRR1 expression through the accumulation of misfolded proteins, leading to a need for increased ribosomal production to manage proteotoxic stress.